26 Dec 2020 Filip Fratev / Micar21

The N501Y and K417N mutations in the spike protein of SARS-CoV-2 alter the interactions with both hACE2 and human derived antibody: A Free energy of perturbation study

Filip Fratev1, 2

1 Micar Innovation (Micar21) Ltd., Persenk 34B, 1407, Sofia, Bulgaria;

2 Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, 1101 N Campbell St, El Paso, TX 79968, USA;

*Corresponding author e-mail: fratev@micar21.com

26 Dec 2020 / 18:00 CET


The N501Y and K417N mutations in spike protein of SARS-CoV-2 and their combination arise questions but the data about their mechanism of action at molecular level is limited. Here, we present Free energy perturbation (FEP) calculations for the interactions of the spike S1 receptor binding domain (RBD) with both the ACE2 receptor and an antibody derived from COVID-19 patients. Our results shown that the S1 RBD-ACE2 interactions were significantly increased whereas those with the STE90-C11 antibody dramatically decreased; about over 100 times. The K417N mutation had much more pronounced effect and in a combination with N501Y fully abolished the antibody effect. This may explain the observed in UK and South Africa more spread of the virus but also raise an important question about the possible human immune response and the success of already available vaccines.

Download full manuscript (PDF 0.9MB)

Link to bioRxiv

22 May 2019 Filip Fratev / Micar21 ACS Med. Chem. Lett.2019106904-910

Discovery of New Classes of Glycine transporter 2 (GlyT2) Inhibitors and GlyT2 Selectivity Studies by Combination of Novel Structural Based Virtual Screening Approach and Free Energy Perturbation (FEP+) Calculations

ACS Med. Chem. Lett.2019106904-910

Publication Date:May 22, 2019


Copyright © 2019 American Chemical Society

20 March 2019 Filip Fratev / Micar21 Nature Scientific Reports DOI : 10.1038/s41598-019-53133-1

An Improvement of the Free Energy Perturbation (FEP+) Sampling Protocol in Case of Flexible protein Ligand Binding Sites

20 March 2019 Filip Fratev / Micar21 Journal of Biomolecular, Structure, and Dynamics, Nov 2019 Accepted In press.

Discovery of New AKT1 Inhibitors by Combination of In silico Structure Based Virtual Screening Approaches and Biological Evaluations

24 February 2013 Filip Fratev / Micar21 Journal of Chemical information and modeling

Discovery of a Novel Selective PPARγ Ligand with Partial Agonist Binding Properties by Integrated in Silico/in Vitro Work Flow.

20 April 2018 Filip Fratev / Micar21 / Schrödinger GmbH ACS Omega

Prediction of Accurate Binding Modes using Combination of classical and accelerated Molecular dynamics and Free Energy Perturbation Calculations: An Application to Toxicity Studies

1 November 2017 Filip Fratev / Micar21 Conference: ACS SWRM

Combination of Structural based Pharmacophore and Docking Virtual Screens: An Efficient Structure-based Protocol for Lead Identification

12 February 2016 Filip Fratev / Micar21 Journal of Biomolecular Structure and Dynamics

PPARγ non-covalent antagonists exhibit mutable binding modes with a similar free energy of binding: A case study

19 February 2016 Filip Fratev / Micar21 Physical Chemistry Chemical Physics

PPARγ helix 12 exhibits an antagonist conformation

8 July 2015 Filip Fratev / Micar21 International Journal of Molecular Sciences

Structural and Dynamical Insight into PPARγ Antagonism: In silico Study of the Ligand-Receptor Interactions of non-Covalent Antagonists

16 April 2015 Filip Fratev / Micar21 Physical Chemistry Chemical Physics

Activation helix orientation of estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations

14 April 2014 Filip Fratev / Micar21 Journal of Chemical information and modeling

Combination of Genetic Screening and Molecular Dynamics as a Useful Tool for Identification of Disease-Related Mutations: ZASP PDZ Domain G54S Mutation Case

10 April 2013 Filip Fratev / Micar21 Proteins: Structure, Function, and Bioinformatics

Structural insight into the UNC-45–myosin complex

2 December 2008 Filip Fratev / Micar21 / Molecular Pharmaceutics

Molecular Basis of Inactive B-RAFWT and B-RAFV600E Ligand Inhibition, Selectivity and Conformational Stability: An in Silico Study

22 July 2009 Filip Fratev / Micar21 / BMC Structural Biology

An in silico study of the molecular basis of B-RAF activation and conformational stability

23 July 2015 Filip Fratev / Micar21 / Mathematics and Computers in Simulation

Molecular dynamics simulation of the human estrogen receptor alpha: contribution to the pharmacophore of the agonists